Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Lymph node-positive prostate cancer: the benefit of local therapy.

Hoffman KE, Kuban DA.

Oncology (Williston Park). 2013 Jul;27(7):655, 660-1. No abstract available.

2.

Management of lymph node-positive prostate cancer: the role of surgery and radiation therapy.

Mitin T, Blute M, Lee R, Efstathiou J.

Oncology (Williston Park). 2013 Jul;27(7):647-55. Review.

3.

N+, M0 prostate cancer: local therapy for systemic disease.

Messing EM.

Oncology (Williston Park). 2013 Jul;27(7):661-2, 668. No abstract available.

4.

Remembering old lessons in prostate cancer: avoiding errors 'in PARPituity'.

Raghavan D.

Oncology (Williston Park). 2013 Jul;27(7):595. No abstract available.

5.

Does local treatment of the prostate in advanced and/or lymph node metastatic disease improve efficacy of androgen-deprivation therapy? A systematic review.

Verhagen PC, Schröder FH, Collette L, Bangma CH.

Eur Urol. 2010 Aug;58(2):261-9. doi: 10.1016/j.eururo.2010.05.027. Epub 2010 May 27. Review.

PMID:
20627403
7.

Detection of occult lymph node metastases in locally advanced node-negative prostate cancer.

Dhar NB, Studer UE.

Nat Clin Pract Urol. 2007 Oct;4(10):520-1. Epub 2007 Aug 28. Review. No abstract available.

PMID:
17726432
8.

Prostate cancer metastasis to supraclavicular lymph node.

Hobdy EM, Shafi NQ, Kummar S.

Clin Adv Hematol Oncol. 2004 Apr;2(4):223-4; discussion 224. No abstract available.

PMID:
16163185
9.

Surgical management of lymph-node-positive prostate cancer: improves symptomatic control.

Wiegand LR, Hernandez M, Pisters LL, Spiess PE.

BJU Int. 2011 Apr;107(8):1238-42. doi: 10.1111/j.1464-410X.2010.09657.x. Epub 2010 Sep 29.

10.

Cancer volume of lymph node metastasis predicts progression in prostate cancer.

Cheng L, Bergstralh EJ, Cheville JC, Slezak J, Corica FA, Zincke H, Blute ML, Bostwick DG.

Am J Surg Pathol. 1998 Dec;22(12):1491-500.

PMID:
9850175
11.

Risk of prostate carcinoma death in patients with lymph node metastasis.

Cheng L, Zincke H, Blute ML, Bergstralh EJ, Scherer B, Bostwick DG.

Cancer. 2001 Jan 1;91(1):66-73.

PMID:
11148561
12.

Re: Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?

Rogers C.

J Urol. 2003 Nov;170(5):1955; author reply 1955-6. No abstract available.

PMID:
14575038
13.

Re: Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results.

Maffezzini M.

J Urol. 2005 Sep;174(3):1151-2; author reply 1152. No abstract available.

PMID:
16094087
14.

Histopathological characteristics of lymph node metastases predict cancer-specific survival in node-positive prostate cancer.

Boormans JL, Wildhagen MF, Bangma CH, Verhagen PC, van Leenders GJ.

BJU Int. 2008 Dec;102(11):1589-93. doi: 10.1111/j.1464-410X.2008.07904.x. Epub 2008 Aug 14.

15.

Re: Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?

Messing EM.

J Urol. 2003 Nov;170(5):1955; author reply 1955-6. No abstract available.

PMID:
14532828
16.

[Lymphadenectomy and surgical procedures in interstitial therapy of prostate cancer].

Sommerkamp H.

Strahlentherapie Sonderb. 1981;76:70-3. German. No abstract available.

PMID:
7303128
17.

[The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].

Heidenreich A, Ohlmann CH.

Aktuelle Urol. 2005 Jun;36(3):219-29. German.

PMID:
16001337
18.

Selective lymph node dissection for castration-resistant prostate cancer.

Busch J, Hinz S, Kempkensteffen C, Erber B, Klopf C, Weikert S, Miller K, Magheli A.

Urol Int. 2012;88(4):441-6. doi: 10.1159/000335206. Epub 2012 Mar 7.

PMID:
22398510
19.
20.

The use of combined radiation therapy and hormonal therapy in the management of lymph node-positive prostate cancer.

Whittington R, Malkowicz SB, Machtay M, Van Arsdalen K, Barnes MM, Broderick GA, Wein AJ.

Int J Radiat Oncol Biol Phys. 1997 Oct 1;39(3):673-80.

PMID:
9336149

Supplemental Content

Support Center